These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25129065)

  • 1. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
    Piccini JP; Al-Khatib SM; Wojdyla DM; Shaw LK; Horton JR; Lokhnygina Y; Anstrom KJ; DeWald T; Allen-LaPointe N; Steinberg BA; Thomas K; Daubert JP; Peterson ED
    Am J Cardiol; 2014 Sep; 114(5):716-22. PubMed ID: 25129065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of antiarrhythmic drug therapy and clinical outcomes in older patients with concomitant atrial fibrillation and coronary artery disease.
    Steinberg BA; Broderick SH; Lopes RD; Shaw LK; Thomas KL; DeWald TA; Daubert JP; Peterson ED; Granger CB; Piccini JP
    Europace; 2014 Sep; 16(9):1284-90. PubMed ID: 24755440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.
    Singh SN; Tang XC; Reda D; Singh BN
    Heart Rhythm; 2009 Feb; 6(2):152-5. PubMed ID: 19187902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year treatment persistence and potential adverse events among patients with atrial fibrillation treated with amiodarone or sotalol: a retrospective claims database analysis.
    Kim MH; Smith PJ; Jhaveri M; Lin J; Klingman D
    Clin Ther; 2011 Nov; 33(11):1668-1681.e1. PubMed ID: 22108302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular arrhythmia and death among atrial fibrillation patients using anti-arrhythmic drugs.
    Friberg L
    Am Heart J; 2018 Nov; 205():118-127. PubMed ID: 30236980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
    Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    J Cardiol; 2016 May; 67(5):471-6. PubMed ID: 26233885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]).
    Singh SN; Singh BN; Reda DJ; Fye CL; Ezekowitz MD; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Antman EM; Falk RH; Lopez B; Tang XC
    Am J Cardiol; 2003 Aug; 92(4):468-72. PubMed ID: 12914883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.
    Allen LaPointe NM; Dai D; Thomas L; Piccini JP; Peterson ED; Al-Khatib SM
    Am J Cardiol; 2015 Feb; 115(3):316-22. PubMed ID: 25491240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose amiodarone versus sotalol for suppression of recurrent symptomatic atrial fibrillation.
    Kochiadakis GE; Igoumenidis NE; Marketou ME; Solomou MC; Kanoupakis EM; Vardas PE
    Am J Cardiol; 1998 Apr; 81(8):995-8. PubMed ID: 9576159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators.
    Roy D; Talajic M; Dorian P; Connolly S; Eisenberg MJ; Green M; Kus T; Lambert J; Dubuc M; Gagné P; Nattel S; Thibault B
    N Engl J Med; 2000 Mar; 342(13):913-20. PubMed ID: 10738049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial.
    Mooss AN; Wurdeman RL; Sugimoto JT; Packard KA; Hilleman DE; Lenz TL; Rovang KS; Arcidi JM; Mohiuddin SM
    Am Heart J; 2004 Oct; 148(4):641-8. PubMed ID: 15459595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug.
    AFFIRM First Antiarrhythmic Drug Substudy Investigators
    J Am Coll Cardiol; 2003 Jul; 42(1):20-9. PubMed ID: 12849654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone versus sotalol for atrial fibrillation.
    Singh BN; Singh SN; Reda DJ; Tang XC; Lopez B; Harris CL; Fletcher RD; Sharma SC; Atwood JE; Jacobson AK; Lewis HD; Raisch DW; Ezekowitz MD;
    N Engl J Med; 2005 May; 352(18):1861-72. PubMed ID: 15872201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D; Opolski G; Torbicki A
    Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
    Wong CK; White HD; Wilcox RG; Criger DA; Califf RM; Topol EJ; Ohman EM;
    Heart; 2002 Oct; 88(4):357-62. PubMed ID: 12231591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use and outcomes of antiarrhythmic therapy in patients with atrial fibrillation receiving oral anticoagulation: results from the ROCKET AF trial.
    Steinberg BA; Hellkamp AS; Lokhnygina Y; Halperin JL; Breithardt G; Passman R; Hankey GJ; Patel MR; Becker RC; Singer DE; Hacke W; Berkowitz SD; Nessel CC; Mahaffey KW; Fox KA; Califf RM; Piccini JP;
    Heart Rhythm; 2014 Jun; 11(6):925-32. PubMed ID: 24833235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.
    Auer J; Weber T; Berent R; Puschmann R; Hartl P; Ng CK; Schwarz C; Lehner E; Strasser U; Lassnig E; Lamm G; Eber B;
    Am Heart J; 2004 Apr; 147(4):636-43. PubMed ID: 15077078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.